【药物名称】GW-5074
化学结构式(Chemical Structure):
参考文献No.38647
标题:Benzylidene-1,3-dihydro-indol-2-one derivs. as receptor tyrosine kinase inhibitors, particularly of Raf kinases
作者:McNutt, R.W. Jr.; Hunter, R.N. III; Jung, D.K.; Lackey, K.E.; Dickerson, S.; Harris, P.A.; Veal, J.M.; Peel, M.R. (Glaxo Group Ltd.)
来源:EP 1003721; WO 9910325
合成路线图解说明:

The key step is the aldol condensation between 5-iodooxiindole (I) and 3,5-dibromo-4-hydroxybenzaldehyde (II) in presence of HCl in HOAc. Alternatively catalytic acid conditions may be used such as p-toluenesulfonic acid in toluene at high temperature.

合成路线图解说明:

5-Iodooxiindole (I) may be prepared by published procedures: 1) Treatment of p-iodoaniline (IV) with the Sandmeyer isonitrosoacetanilide Isatin synthesis, by condensation with chloral hydrate (A) and hydroxylamine followed by cyclization with concentrated sulfuric acid and hydrolysis with water yields isatin (V). The conversion of (V) to (I) may be conducted via the Wolf-Kishner reduction by treatment with hydrazine hydrate in ethanol at 20-80 C to give hydrazide (VI). The conversion from (VI) to (I) may be performed by treatment with sodium ethoxide in a suitable solvent such as ethanol at 0-80 C. 2) Iodoindole (VII) may be converted to the bromo derivative (VIII) by tretment with pyridinium perbromide in tert-butyl alcohol. The last step of the synthesis is the treatment of (VIII) with H2 over Pd/C in anhydrous ethanol, or by treatment with a solution of NH4Cl followed by treatment with activated zinc in THF. 3) Iodoaniline (IV) can be converted to the sulfanylderivative (IX) by treatment with tert-butyl hypochlorite, followed by treatment with ethyl methylthioacetate (B) and triethylamine in dichloromethane. Finally the conversion of (IX) to the desired product may be conducted by means of W-2 Raney-Ni in EtOH or by treatment with activated zinc in THF.

合成路线图解说明:

Also 3,5-dibromo-4-hydroxybenzaldehyde (II) is commercially available but it may also be prepared by published procedures: 1) The synthesis can be performed by treating 2,6-dibromophenol (X) with hexamethylenetetramine in acetic acid. 2) Alternatively the synthetic pathway can be the oxidation of 3,5-dibromo-4-hydroxytoluene (XI) by means of DDQ in dioxane with a small amount of water.

Drug Information Express,Drug R&D,Chemical Database,Patent Search.
Copyright © 2006-2024 Drug Future. All rights reserved.Contact Us